The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1960, 84, 562 -568
Copyright © 1960 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Veen, J.
Right arrow Articles by Prins, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Veen, J.
Right arrow Articles by Prins, A.

Studies of the Significance of the Recall Phenomenon in the Antibody Response to Adenovirus Vaccine and Infection

J. van der Veen and A. Prins1

from the Department of Bacteriology and Virology, R. K. University, St. Elisabeth-Hospital, Tilburg, The Netherlands

Abstract

The antibody responses of military recruits following administration of type 4 or 7 adenovirus vaccine and of patients suffering infections with adenovirus type 4 or 14 were studied. Type 4 vaccine induced significant neutralizing antibody against type 4 virus, a slight increase in antibody against types 3 and 14, and no antibody against type 7. The antibody-producing capacity of type 7 vaccine was greater than that of type 4 vaccine. Type 7 vaccine produced a marked neutralizing antibody response to types 3, 7 and 14, and a slight increase in antibody against type 4 only. The response to types 4 and 7 vaccine as measured with the complement-fixation test was poor in comparison to the neutralizing antibody response and tended to be type-specific. An assay of neutralizing antibody in sera from recruits showed that antibody against types 3, 7 and 14 was common at the time of the vaccination study or previously, whereas antibody against type 4 was less prevalent. It appeared that increases in heterotypic neutralizing antibody occurred more frequently when heterotypic antibody was present in the prevaccination or preinfection serum at a level of 1:2 to 1:16 than when no antibody was found The findings are discussed and compared to those of other studies. The data support the concept that the heterotypic antibody response to adenovirus vaccination or infection is conditioned by the recall phenomenon.

Footnotes

1 Lieutenant, Medical Services, Royal Netherlands Army.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1960 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1960 by The American Association of Immunologists, Inc. All rights reserved.